Natriuretic peptides and cardio-renal disease

Massimo Volpe

Research output: Contribution to journalArticlepeer-review


The natriuretic peptide (NP) system is an important endocrine, autocrine and paracrine system, consisting of a family of peptides which provide cardiac, renal and vascular effects that, through their beneficial physiological actions, play a key role in maintaining overall cardiovascular health. Traditionally, the pathophysiological origins of cardio-renal disease have been viewed as the domain of the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system (SNS), with inappropriate activation of both systems leading to deleterious changes in cardio-renal function and structure. Therapies designed to suppress the RAAS and the SNS have been routinely employed to address the consequences of cardio-renal disease. However, it is now becoming increasingly apparent that enhancing the beneficial physiological effects of the NP system may represent an attractive alternative therapeutic approach to counter the pathophysiological effects of disease. In particular, innovative therapeutic strategies aimed at enhancing the physiological benefits afforded by NPs while simultaneously suppressing the RAAS are generating increasing interest as potential treatment options for the management of cardio-renal disease.

Original languageEnglish
Pages (from-to)630-639
Number of pages10
JournalInternational Journal of Cardiology
Issue number3
Publication statusPublished - Oct 20 2014


  • Chronic kidney disease
  • Heart failure
  • Hypertension
  • Natriuretic peptide
  • Neprilysin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)


Dive into the research topics of 'Natriuretic peptides and cardio-renal disease'. Together they form a unique fingerprint.

Cite this